KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Exchange Rate Effect (2016 - 2025)

Arbutus Biopharma's Exchange Rate Effect history spans 13 years, with the latest figure at -$12000.0 for Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 340.0% year-over-year to -$12000.0; the TTM value through Sep 2025 reached -$20000.0, down 900.0%, while the annual FY2024 figure was -$49000.0, 296.0% down from the prior year.
  • Exchange Rate Effect for Q3 2025 was -$12000.0 at Arbutus Biopharma, down from $21000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $44000.0 in Q3 2021 and bottomed at -$44000.0 in Q1 2021.
  • The 5-year median for Exchange Rate Effect is $1500.0 (2023), against an average of -$1750.0.
  • The largest annual shift saw Exchange Rate Effect skyrocketed 450.0% in 2023 before it crashed 700.0% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at $5000.0 in 2021, then tumbled by 180.0% to -$4000.0 in 2022, then surged by 450.0% to $14000.0 in 2023, then crashed by 335.71% to -$33000.0 in 2024, then soared by 63.64% to -$12000.0 in 2025.
  • Per Business Quant, the three most recent readings for ABUS's Exchange Rate Effect are -$12000.0 (Q3 2025), $21000.0 (Q2 2025), and $4000.0 (Q1 2025).